Specialty Pharmaceutical Company dedicated to patients living with chronic conditions

Investor Relations
BioDelivery Science International, Inc
919-582-9050

BioDelivery Sciences Acquires U.S. Commercial Rights to Symproic®
Thank you. We will get back to you soon